Morphologic and Microvascular Differences Between Macular Neovascularization With and Without Subretinal Fibrosis.

Autor:	Roberts PK; Department of Ophthalmology and Optometry of the Medical University of Vienna, Vienna, Austria., Schranz M; Department of Ophthalmology and Optometry of the Medical University of Vienna, Vienna, Austria., Motschi A; Center for Medical Physics and Biomedical Engineering of the Medical University of Vienna, Vienna, Austria., Desissaire S; Center for Medical Physics and Biomedical Engineering of the Medical University of Vienna, Vienna, Austria., Hacker V; Department of Ophthalmology and Optometry of the Medical University of Vienna, Vienna, Austria., Pircher M; Center for Medical Physics and Biomedical Engineering of the Medical University of Vienna, Vienna, Austria., Sacu S; Department of Ophthalmology and Optometry of the Medical University of Vienna, Vienna, Austria., Buehl W; Department of Ophthalmology and Optometry of the Medical University of Vienna, Vienna, Austria., Hitzenberger CK; Center for Medical Physics and Biomedical Engineering of the Medical University of Vienna, Vienna, Austria., Schmidt-Erfurth U; Department of Ophthalmology and Optometry of the Medical University of Vienna, Vienna, Austria.
Jazyk:	angličtina
Zdroj:	Translational vision science & technology [Transl Vis Sci Technol] 2021 Dec 01; Vol. 10 (14), pp. 1.
DOI:	10.1167/tvst.10.14.1
Abstrakt:	Purpose: To evaluate morphologic and microvascular differences between eyes with and without subretinal fibrosis (SF) caused by neovascular age-related macular degeneration (nAMD). Methods: Patients with nAMD with a minimum history of 12 months of anti-VEGF treatment were prospectively included in this cross-sectional study. Patients were imaged using standard imaging, swept-source optical coherence tomography angiography for quantitative microvascular analysis and polarization-sensitive OCT as an ancillary method for automated SF segmentation. The presence of reticular pseudodrusen, hyperreflective foci (HRF), and outer retinal tubulation (ORT) were also evaluated. Results: Sixty eyes of 60 participants (37 female) with nAMD and a mean 3.1 (±2.7)-year history of anti-VEGF treatment were included, 20 (33%) of which were diagnosed with SF. Eyes with SF had a higher prevalence of ORT (P < 0.001) and a lower prevalence of HRF (P = 0.004) than eyes without SF. Fifty eyes were analyzed quantitatively for microvascular biomarkers. Eyes with SF had a larger greatest vascular caliber (P = 0.001) and greatest linear diameter (P = 0.042), a larger microvascular neovascularization (MNV) area (P = 0.026), larger vessel area (P = 0.037), higher number of vessel junctions (P = 0.025), longer total vessel length (P = 0.027), higher number of vessel endpoints (P = 0.007), and higher endpoint density (P = 0.047). Conclusions: This multimodal imaging approach demonstrated in vivo microvascular and morphological differences in eyes with and without SF. Eyes with SF tend to have larger MNV lesions with thicker vessels and are often associated with the presence of ORT. Translational Relevance: This study points out imaging biomarkers in patients with SF, which may help identifying high-risk patients.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu